M&A Deal Summary

Juno Pharmaceuticals Acquires Omega Laboratories

On May 15, 2023, Juno Pharmaceuticals acquired life science company Omega Laboratories from Sagent Pharmaceuticals

Acquisition Highlights
  • This is Juno Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Juno Pharmaceuticals’ 1st transaction in the United States.
  • This is Juno Pharmaceuticals’ 1st transaction in Ohio.

M&A Deal Summary
Date 2023-05-15
Target Omega Laboratories
Sector Life Science
Buyer(s) Juno Pharmaceuticals
Sellers(s) Sagent Pharmaceuticals
Deal Type Divestiture

Target

Omega Laboratories

Mogadore, Ohio, United States
Omega Laboratories is a pharmaceutical and specialty healthcare products company focused on manufacturing, innovation, quality, and rapid R&D development for the Canadian and global markets. The Hospital Division manufactures sterile vial format injectables, antiseptics, oncology injectables, and non-injectable pharmaceuticals for the Canadian and export markets and the Allergy and Phlebology Divisions provide specialized products and services for Canadian customers. Omega Laboratories was founded in 1958 and is based in Mogadore, Ohio.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Juno Pharmaceuticals

Mississauga, Ontario, Canada
Category Company
Founded 2012
Sector Life Science
DESCRIPTION

Juno Pharmaceuticals is a specialty pharmaceutical company with a focus on injectable generic drugs sold through hospital channels. Juno Pharmaceuticals was founded in 2012 and is based in Mississauga, Ontario.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Ohio) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1

Seller(S) 1

SELLER

Sagent Pharmaceuticals

Schaumburg, Illinois, United States
Category Company
Founded 2006
Sector Life Science
Employees440
Revenue 318M USD (2015)
DESCRIPTION

Sagent Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products with a specific emphasis on injectables.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Ohio) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-01 Omega Laboratories

Mogadore, Ohio, United States

Omega Laboratories is a pharmaceutical and specialty healthcare products company focused on manufacturing, innovation, quality, and rapid R&D development for the Canadian and global markets. The Hospital Division manufactures sterile vial format injectables, antiseptics, oncology injectables, and non-injectable pharmaceuticals for the Canadian and export markets and the Allergy and Phlebology Divisions provide specialized products and services for Canadian customers. Omega Laboratories was founded in 1958 and is based in Mogadore, Ohio.

Buy CA$95M
Mergr

Product

Company

Legal